Digitisation | December 19, 2025
Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
The update promises to revolutionize laboratory workflows by optimizing resources
The update promises to revolutionize laboratory workflows by optimizing resources
Cobas infinity edge is designed as an open platform, allowing healthcare professionals to easily access and adopt third-party innovators’ new digital tools and medically-relevant applications via the Roche digital marketplace
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology
Three new molecular diagnostic test panels for influenza and other common respiratory illnesses can be run together or alone using one patient sample
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
The new assay consolidates screening for four major viral threats into a single workflow
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Subscribe To Our Newsletter & Stay Updated
